Nathalie Auger

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Christophe Massard, Stefan Michiels, Charles Ferté et al. · Cancer Discovery · 2017 · 747 citations

A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

Elisabetta Marangoni, Anne Vincent‐Salomon, Nathalie Auger et al. · Clinical Cancer Research · 2007 · 405 citations

EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients

David Planchard, Yohann Loriot, Fabrice André et al. · Annals of Oncology · 2015 · 312 citations

Medicine, Egfr-independent Mechanisms, Immunology +5

Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Emma Pailler, Julien Adam, Amélie Barthelemy et al. · Journal of Clinical Oncology · 2013 · 279 citations · Full text

Molecular profiling of patient-derived breast cancer xenografts

Fabien Reyal, Charlotte Guyader, Charles Decraene et al. · Breast Cancer Research · 2012 · 188 citations · Full text